Drug Firms Battle In Del., Calif. Over Shared LLC, $60M IP
Pharmaceutical developer Syntrix Biosystems Inc. on Friday asked the Delaware Chancery Court to dissolve a company it formed with PharmaInvest LLC to develop a drug for autoimmune diseases, saying PharmaInvest failed...To view the full article, register now.
Already a subscriber? Click here to view full article